News

For the 300mg dosing group, 61% of patients receiving the drug completed the study in normal heart rhythm, as compared to 43% of all patients receiving placebo, with

The decision, which is subject to appeal, prevents Indian generics business Ranbaxy from launching its drug before Lipitor’s basic patent expires in November 2011. “Today’s decision is another

The drug, which is marketed as Seretide in Europe, is the company’s biggest product with $5.6 billion of sales last year. GSK said that the study, which assessed

The agreement includes an upfront payment from Bristol-Myers Squibb of $7.5 million to Medivir. Sweden-based Medivir also may receive pre-specified development and regulatory milestones totaling approximately $97 million

Under this new order, the US Centers for Disease Control and Prevention (CDC) has agreed to procure10 million doses in addition to the 182.5 million doses of ACAM2000

The California-based company is developing Viramidine for use in treating chronic hepatitis C in combination with pegylated interferon, which Valeant hoped to prove would be as efficacious as

The board has appointed James Cornelius, chairman of Guidant Corporation, to act as interim CEO, while Mr Dolan has agreed to stay on as an adviser. Senior vice

A jury found that Abbott willfully infringed Innogenetic's patent on a method of genotyping the hepatitis C virus and Abbot has been ordered to pay $7 million in

The most commonly prescribed medications for treating conditions such as arthritis are non-steroidal anti-inflammatory drugs (NSAIDs) which include ibuprofen. These drugs reduce pain, fever and inflammation but also